Published in J Cell Physiol on February 01, 2005
A translocated bacterial protein protects vascular endothelial cells from apoptosis. PLoS Pathog (2006) 1.49
Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen (2012) 1.10
Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns. Proc Natl Acad Sci U S A (2013) 0.88
Prostaglandin E₂-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells. Br J Pharmacol (2013) 0.82
Outer membrane protein A of Escherichia coli K1 selectively enhances the expression of intercellular adhesion molecule-1 in brain microvascular endothelial cells. Microbes Infect (2007) 0.80
Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium. Am J Physiol Cell Physiol (2011) 0.79
Immune-modulating therapy in acute pancreatitis: fact or fiction. World J Gastroenterol (2014) 0.78
Modulation of acute inflammation by a chitin-binding lectin from Araucaria angustifolia seeds via mast cells. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.78
Paeoniflorin suppresses the expression of intercellular adhesion molecule-1 (ICAM-1) in endotoxin-treated human monocytic cells. Br J Pharmacol (2011) 0.77
Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun (2016) 0.77
Toll-like receptors play a crucial part in the pathophysiological activity of antiphospholipid antibodies. Auto Immun Highlights (2011) 0.76
Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats. Exp Ther Med (2013) 0.76
Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain Barrier. Int J Mol Sci (2016) 0.75
Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J (2004) 3.29
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood (2009) 2.64
ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost (2007) 2.32
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol (2003) 1.99
PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol (2006) 1.76
von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood (2009) 1.71
Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome. Am J Cardiol (2008) 1.71
Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA (2004) 1.60
Tiplaxtinin impairs nutritionally induced obesity in mice. Thromb Haemost (2006) 1.55
Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun (2006) 1.51
Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact. Thromb Haemost (2005) 1.44
Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res (2010) 1.36
The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res (2006) 1.26
Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost (2008) 1.24
TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. J Immunol (2006) 1.22
Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis (2005) 1.19
The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: possible contribution to elevated plasma levels of soluble TNF alpha receptors. Atherosclerosis (2005) 1.16
Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage. Blood (2005) 1.15
Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol (2007) 1.14
Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J (2009) 1.14
ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol (2005) 1.12
Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol (2002) 1.10
Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res (2004) 1.10
Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study. Blood (2006) 1.07
Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc Res (2009) 1.06
Characterization of eIF3k: a newly discovered subunit of mammalian translation initiation factor elF3. Eur J Biochem (2003) 1.03
Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol (2007) 1.03
Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. Exp Cell Res (2003) 0.97
Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci (2003) 0.96
A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin- and nonintegrin-related defects in different steps of leukocyte adhesion. J Immunol (2011) 0.95
HDLs activate ADAM17-dependent shedding. J Cell Physiol (2008) 0.94
Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates. J Biol Chem (2013) 0.92
Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation. J Biol Chem (2010) 0.92
Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis (2004) 0.91
Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFalpha receptors to PAI-1 levels. Thromb Haemost (2002) 0.89
p38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells. Stem Cells Dev (2010) 0.87
FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity. J Cell Physiol (2006) 0.87
Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase. J Cell Sci (2011) 0.87
Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag (2008) 0.86
Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells. J Cell Sci (2005) 0.85
Effect of atorvastatin on adhesive phenotype of human endothelial cells activated by tumor necrosis factor alpha. J Cardiovasc Pharmacol (2003) 0.85
Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol (2003) 0.85
A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor. Biochemistry (2003) 0.85
Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk. PLoS One (2011) 0.84
Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting. Heart Vessels (2010) 0.84
Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol (2003) 0.83
Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study. Atherosclerosis (2003) 0.82
[The two sides of ADAM17 in inflammation: implications in atherosclerosis and obesity]. Med Sci (Paris) (2009) 0.82
Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence. The PRIME Study (Prospective Epidemiological Study of MI). Thromb Haemost (2003) 0.82
Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost (2004) 0.81
Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology (2015) 0.80
DLG1/SAP97 modulates transforming growth factor alpha bioavailability. Biochim Biophys Acta (2008) 0.80
Palmitoylation of TNF alpha is involved in the regulation of TNF receptor 1 signalling. Biochim Biophys Acta (2012) 0.80
MRI follow-up of TNF-dependent differential progression of atherosclerotic wall-thickening in mouse aortic arch from early to advanced stages. Atherosclerosis (2007) 0.80
Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response. Thromb Res (2008) 0.80
Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3). Arterioscler Thromb Vasc Biol (2012) 0.80
The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic stem cells. PLoS One (2012) 0.80
Development of a genotype 325-specific proCPU/TAFI ELISA. Arterioscler Thromb Vasc Biol (2003) 0.79
Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infarction. Blood (2002) 0.78
Respective contribution of conventional risk factors and antihypertensive treatment to stable angina pectoris and acute coronary syndrome as the first presentation of coronary heart disease: the PRIME Study. Eur J Cardiovasc Prev Rehabil (2009) 0.78
Proinflammatory properties of murine aortic endothelial cells exclusively expressing a non cleavable form of TNFalpha. Effect on tumor necrosis factor alpha receptor type 2. Thromb Haemost (2004) 0.77
Modulation of PAI-1 and proMMP-9 syntheses by soluble TNFalpha and its receptors during differentiation of the human monocytic HL-60 cell line. J Cell Physiol (2003) 0.77
Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome. Thromb Haemost (2007) 0.76
Anti-phospholipid/cofactor antibodies in three cases of persistent polyclonal B lymphocytosis. Br J Haematol (2002) 0.76
A nonradioisotope chemiluminescent assay for evaluation of 2-deoxyglucose uptake in 3T3-L1 adipocytes. Effect of various carbonyls species on insulin action. Biochimie (2012) 0.76
PPARalpha deficiency does not modify age dependency but prevents high fat diet increase in plasma PAI-1 as well as insulin resistance. Thromb Haemost (2004) 0.75
[The link between molecules produced by the adipose tissue, obesity and atherothrombosis]. Presse Med (2005) 0.75
Prospective analysis of factor XI deficiencies in the Marseilles area identified four novel mutations among 12 consecutive unrelated families. Blood Coagul Fibrinolysis (2009) 0.75
Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women. Thromb Haemost (2007) 0.75
Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution. Blood Coagul Fibrinolysis (2009) 0.75